Stochastic modelling of the effects of human-mobility restriction and viral infection characteristics on the spread of COVID-19

After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 11; no. 1; pp. 6856 - 10
Main Authors Ando, Shiho, Matsuzawa, Yuki, Tsurui, Hiromichi, Mizutani, Tetsuya, Hall, Damien, Kuroda, Yutaka
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 25.03.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown.
AbstractList After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown.
After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown.After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown.
Abstract After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown.
ArticleNumber 6856
Author Tsurui, Hiromichi
Mizutani, Tetsuya
Hall, Damien
Ando, Shiho
Matsuzawa, Yuki
Kuroda, Yutaka
Author_xml – sequence: 1
  givenname: Shiho
  surname: Ando
  fullname: Ando, Shiho
  organization: Department of Biotechnology and Life Sciences, Tokyo University of Agriculture and Technology
– sequence: 2
  givenname: Yuki
  surname: Matsuzawa
  fullname: Matsuzawa, Yuki
  organization: Department of Biotechnology and Life Sciences, Tokyo University of Agriculture and Technology
– sequence: 3
  givenname: Hiromichi
  surname: Tsurui
  fullname: Tsurui, Hiromichi
  organization: Department of Immunological Diagnosis, Juntendo University School of Medicine
– sequence: 4
  givenname: Tetsuya
  surname: Mizutani
  fullname: Mizutani, Tetsuya
  organization: Research and Education Center for Prevention of Global Infectious Diseases of Animals, Tokyo University of Agriculture and Technology
– sequence: 5
  givenname: Damien
  surname: Hall
  fullname: Hall, Damien
  organization: Department of Life Sciences and Applied Chemistry, Nagoya Institute of Technology, WPI Nano Life Science Institute, Kanazawa University, Department of Applied Physics, Alto University
– sequence: 6
  givenname: Yutaka
  surname: Kuroda
  fullname: Kuroda, Yutaka
  email: ykuroda@cc.tuat.ac.jp
  organization: Department of Biotechnology and Life Sciences, Tokyo University of Agriculture and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33767233$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNUREvpH2CBIrFhE_AjduwNEpryGKlSFzy2luPHjEeJPdiZSl3x17mZaaHtYrLxI-d8uvf6vKxOYoquql5j9B4jKj6UFjMpGkRwIzgiXUOeVWcEtawhlJCTB_vT6qKUDYKPEdli-aI6pbTjHaH0rPrzfUpmrcsUTD0m64YhxFWdfD2tXe28d2Yq83G9G3VsxtSHIUy3dXZlysFMIcVaR1vfhKyHOsRZP98BMmszuRxmMhDiHli22Wk78xbXv5aXDZavqudeD8Vd3K3n1c8vn38svjVX11-Xi09XjeGYT41BhAtuhUWOEk1k38Gp1x5xbTlD1hIpTc9hT23vWa8Nwrpn0hhvNfOInlfLA9cmvVHbHEadb1XSQe0vUl4pnaHUwSkEbXPXIi-RaD1H2nTIG-eIIEJgY4H18cDa7vrRWePiBN0_gj7-E8NardKN6qRsOcUAeHcHyOn3DkapxlAMzF5Hl3ZFEYY4ES1iDKRvn0g3aZcjjEoRjlnXMsHkURWDZ2eUIAGqNw_r_lfwfRpAIA4Ck1Mp2XllwqTnB4U2wqAwUnP21CF7CrKn9tlTBKzkifWeftREDybIBcTO5f9lH3H9BWyu7P8
CitedBy_id crossref_primary_10_1016_j_jfranklin_2022_03_035
crossref_primary_10_1007_s12551_023_01176_0
crossref_primary_10_1016_j_cplett_2022_139767
crossref_primary_10_3390_healthcare11050752
crossref_primary_10_1007_s11538_023_01152_5
crossref_primary_10_1146_annurev_publhealth_052220_093319
crossref_primary_10_1007_s12551_022_01033_6
crossref_primary_10_1108_EJMBE_07_2021_0215
Cites_doi 10.1016/0301-4622(79)85012-7
10.1038/d41586-020-01003-6
10.1016/j.jinf.2020.04.024
10.1088/1478-3975/aba6d0
10.1093/oxfordjournals.epirev.a036121
10.1002/jmv.25750
10.3201/eid1211.060255
10.1038/s41577-020-0316-3
10.1038/s41586-020-2196-x
10.3201/eid1201.051370
10.1016/j.vaccine.2009.08.010
10.1016/S0140-6736(20)30211-7
10.1056/NEJMoa2001017
10.1007/978-0-387-33012-9_57
10.1098/rsif.2007.1197
10.1038/nature04795
10.1016/j.virol.2006.03.020
10.1096/fj.202001700RR
10.1183/13993003.01260-2020
10.1038/s41591-020-0869-5
10.1073/pnas.2004064117
10.1016/j.jinf.2020.06.073
10.12688/wellcomeopenres.15808.1
10.7554/eLife.57149
ContentType Journal Article
Copyright The Author(s) 2021
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-021-86027-2
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef


Publicly Available Content Database
MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 10
ExternalDocumentID oai_doaj_org_article_0eff6e40f9084f60ac70fcee282881cd
PMC7994631
33767233
10_1038_s41598_021_86027_2
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  grantid: KAKENHI-18H02385
  funderid: http://dx.doi.org/10.13039/501100001691
– fundername: Japan Society for the Promotion of Science
  grantid: KAKENHI-18H02385
– fundername: ;
  grantid: KAKENHI-18H02385
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
COVID
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c616t-c02686d8d0e32a29b786dbaf06ad650dd299cb6d653dbf5bac01ab59ccfda5f03
IEDL.DBID M48
ISSN 2045-2322
IngestDate Wed Aug 27 01:09:40 EDT 2025
Thu Aug 21 14:08:18 EDT 2025
Fri Jul 11 03:39:51 EDT 2025
Wed Aug 13 08:04:39 EDT 2025
Wed Aug 13 09:18:14 EDT 2025
Thu Jan 02 22:36:58 EST 2025
Thu Apr 24 22:51:39 EDT 2025
Tue Jul 01 01:07:47 EDT 2025
Fri Feb 21 02:39:48 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c616t-c02686d8d0e32a29b786dbaf06ad650dd299cb6d653dbf5bac01ab59ccfda5f03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-86027-2
PMID 33767233
PQID 2505253208
PQPubID 2041939
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_0eff6e40f9084f60ac70fcee282881cd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7994631
proquest_miscellaneous_2506284055
proquest_journals_2615745859
proquest_journals_2505253208
pubmed_primary_33767233
crossref_citationtrail_10_1038_s41598_021_86027_2
crossref_primary_10_1038_s41598_021_86027_2
springer_journals_10_1038_s41598_021_86027_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-03-25
PublicationDateYYYYMMDD 2021-03-25
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-25
  day: 25
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Moghadas (CR9) 2020; 2
Fang, Nie, Penny (CR25) 2020; 92
Hardt (CR33) 1979; 10
Ishii (CR7) 2006; 351
Bell (CR19) 2006; 12
Gousseff (CR15) 2020; 81
Flaxman (CR10) 2020; 2
Ferguson (CR11) 2006; 442
Mizutani (CR6) 2006; 581
Bahl (CR5) 2020; 2
Muller (CR29) 2020; 17
Zhu (CR2) 2020; 382
Wölfel, Corman, Guggemos, Seilmaier, Zange, Müller, Niemeyer, Jones, Vollmar, Rothe, Hoelscher (CR31) 2020; 581
Tindale, Stockdale, Coombe, Garlock, Lau, Saraswat, Zhang, Chen, Wallinga, Colijn (CR32) 2020; 9
Moghadas (CR27) 2020; 117
Fine (CR17) 1993; 15
CR3
Glass (CR22) 2006; 12
CR8
Bell (CR18) 2006; 12
CR28
Imai (CR4) 2020; 5
CR26
Miller, Garcia Beltran, Bard, Gogakos, Anahtar, Astudillo, Yang, Thierauf, Fisch, Mahowald, Fitzpatrick (CR16) 2020; 34
He (CR30) 2020; 26
Chen (CR1) 2020; 395
Law, Leung, Xu (CR13) 2020; 26
Ferguson, Nicoll, Schwartz (CR20) 2009; 27
Caley, Philp, McCracken (CR21) 2008; 5
Adam (CR12) 2020; 580
Cheng (CR24) 2020; 81
Ota (CR14) 2020; 20
Esposito (CR23) 2020; 55
TE Miller (86027_CR16) 2020; 34
86027_CR8
X He (86027_CR30) 2020; 26
D Bell (86027_CR19) 2006; 12
Y Fang (86027_CR25) 2020; 92
M Gousseff (86027_CR15) 2020; 81
K Ishii (86027_CR7) 2006; 351
M Ota (86027_CR14) 2020; 20
T Mizutani (86027_CR6) 2006; 581
D Adam (86027_CR12) 2020; 580
N Zhu (86027_CR2) 2020; 382
86027_CR28
86027_CR26
PE Fine (86027_CR17) 1993; 15
NM Ferguson (86027_CR11) 2006; 442
SM Moghadas (86027_CR27) 2020; 117
SL Hardt (86027_CR33) 1979; 10
S Flaxman (86027_CR10) 2020; 2
M Muller (86027_CR29) 2020; 17
SM Moghadas (86027_CR9) 2020; 2
P Bahl (86027_CR5) 2020; 2
N Imai (86027_CR4) 2020; 5
LC Tindale (86027_CR32) 2020; 9
P Caley (86027_CR21) 2008; 5
N Chen (86027_CR1) 2020; 395
86027_CR3
D Bell (86027_CR18) 2006; 12
VC Cheng (86027_CR24) 2020; 81
R Wölfel (86027_CR31) 2020; 581
S Esposito (86027_CR23) 2020; 55
N Ferguson (86027_CR20) 2009; 27
RJ Glass (86027_CR22) 2006; 12
SK Law (86027_CR13) 2020; 26
References_xml – volume: 10
  start-page: 239
  issue: 3–4
  year: 1979
  end-page: 243
  ident: CR33
  article-title: Rates of diffusion controlled reactions in one, two and three dimensions
  publication-title: Biophys. Chem.
  doi: 10.1016/0301-4622(79)85012-7
– volume: 2
  start-page: 2
  year: 2020
  ident: CR10
  article-title: Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
  publication-title: Nature
– volume: 580
  start-page: 316
  issue: 7803
  year: 2020
  end-page: 318
  ident: CR12
  article-title: Special report: The simulations driving the world's response to COVID-19
  publication-title: Nature
  doi: 10.1038/d41586-020-01003-6
– volume: 81
  start-page: 107
  issue: 1
  year: 2020
  end-page: 114
  ident: CR24
  article-title: The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.04.024
– volume: 17
  start-page: 065007
  year: 2020
  ident: CR29
  article-title: Testing of asymptomatic individuals for fast feedback-control of COVID-19 pandemics
  publication-title: Phys. Biol.
  doi: 10.1088/1478-3975/aba6d0
– volume: 15
  start-page: 265
  issue: 2
  year: 1993
  end-page: 302
  ident: CR17
  article-title: Herd immunity: History, theory, practice
  publication-title: Epidemiol. Rev.
  doi: 10.1093/oxfordjournals.epirev.a036121
– volume: 92
  start-page: 645
  issue: 6
  year: 2020
  end-page: 659
  ident: CR25
  article-title: Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25750
– volume: 12
  start-page: 1671
  issue: 11
  year: 2006
  end-page: 1681
  ident: CR22
  article-title: Targeted social distancing design for pandemic influenza
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1211.060255
– ident: CR8
– volume: 20
  start-page: 351
  issue: 6
  year: 2020
  ident: CR14
  article-title: Will we see protection or reinfection in COVID-19?
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0316-3
– volume: 581
  start-page: 465
  issue: 7809
  year: 2020
  end-page: 469
  ident: CR31
  article-title: Virological assessment of hospitalized patients with COVID-2019
  publication-title: Nature
  doi: 10.1038/s41586-020-2196-x
– volume: 12
  start-page: 88
  issue: 1
  year: 2006
  end-page: 94
  ident: CR18
  article-title: Non-pharmaceutical interventions for pandemic influenza, national and community measures
  publication-title: Emerg. Infect. Dis.
– volume: 12
  start-page: 81
  issue: 1
  year: 2006
  end-page: 87
  ident: CR19
  article-title: Non-pharmaceutical interventions for pandemic influenza, international measures
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1201.051370
– volume: 27
  start-page: 6383
  issue: 45
  year: 2009
  end-page: 6386
  ident: CR20
  article-title: SIP 5: Social distancing during a pandemic. Not sexy, but sometimes effective: Social distancing and non-pharmaceutical interventions
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.08.010
– volume: 395
  start-page: 507
  issue: 10223
  year: 2020
  end-page: 513
  ident: CR1
  article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30211-7
– volume: 382
  start-page: 727
  issue: 8
  year: 2020
  end-page: 733
  ident: CR2
  article-title: A novel coronavirus from patients with pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 581
  start-page: 323
  year: 2006
  end-page: 326
  ident: CR6
  article-title: Characterization of persistent SARS-CoV infection in Vero E6 cells
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-0-387-33012-9_57
– volume: 5
  start-page: 631
  issue: 23
  year: 2008
  end-page: 639
  ident: CR21
  article-title: Quantifying social distancing arising from pandemic influenza
  publication-title: J. R. Soc. Interface
  doi: 10.1098/rsif.2007.1197
– volume: 442
  start-page: 448
  issue: 7101
  year: 2006
  end-page: 452
  ident: CR11
  article-title: Strategies for mitigating an influenza pandemic
  publication-title: Nature
  doi: 10.1038/nature04795
– volume: 351
  start-page: 368
  issue: 2
  year: 2006
  end-page: 380
  ident: CR7
  article-title: Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
  publication-title: Virology
  doi: 10.1016/j.virol.2006.03.020
– volume: 34
  start-page: 13877
  issue: 10
  year: 2020
  end-page: 13884
  ident: CR16
  article-title: Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital
  publication-title: FASEB J.
  doi: 10.1096/fj.202001700RR
– ident: CR3
– volume: 55
  start-page: 6
  year: 2020
  ident: CR23
  article-title: Universal use of face masks for success against COVID-19: Evidence and implications for prevention policies
  publication-title: Eur. Respir. J.
  doi: 10.1183/13993003.01260-2020
– volume: 26
  start-page: 672
  issue: 5
  year: 2020
  end-page: 675
  ident: CR30
  article-title: Temporal dynamics in viral shedding and transmissibility of COVID-19
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0869-5
– volume: 2
  start-page: 2
  year: 2020
  ident: CR5
  article-title: Airborne or droplet precautions for health workers treating COVID-19?
  publication-title: J. Infect. Dis.
– volume: 117
  start-page: 9122
  issue: 16
  year: 2020
  end-page: 9126
  ident: CR27
  article-title: Projecting hospital utilization during the COVID-19 outbreaks in the United States
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.2004064117
– volume: 81
  start-page: 816
  issue: 5
  year: 2020
  end-page: 846
  ident: CR15
  article-title: Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.06.073
– volume: 5
  start-page: 59
  year: 2020
  ident: CR4
  article-title: Adoption and impact of non-pharmaceutical interventions for COVID-19
  publication-title: Wellcome Open Res.
  doi: 10.12688/wellcomeopenres.15808.1
– volume: 26
  start-page: 264
  issue: 3
  year: 2020
  end-page: 265
  ident: CR13
  article-title: Is reinfection possible after recovery from COVID-19?
  publication-title: Hong Kong Med. J.
– volume: 9
  start-page: e57149
  year: 2020
  ident: CR32
  article-title: Evidence for transmission of COVID-19 prior to symptom onset
  publication-title: Elife
  doi: 10.7554/eLife.57149
– ident: CR28
– ident: CR26
– volume: 2
  start-page: 2
  year: 2020
  ident: CR9
  article-title: The implications of silent transmission for the control of COVID-19 outbreaks
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 55
  start-page: 6
  year: 2020
  ident: 86027_CR23
  publication-title: Eur. Respir. J.
  doi: 10.1183/13993003.01260-2020
– volume: 10
  start-page: 239
  issue: 3–4
  year: 1979
  ident: 86027_CR33
  publication-title: Biophys. Chem.
  doi: 10.1016/0301-4622(79)85012-7
– volume: 395
  start-page: 507
  issue: 10223
  year: 2020
  ident: 86027_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30211-7
– volume: 20
  start-page: 351
  issue: 6
  year: 2020
  ident: 86027_CR14
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0316-3
– volume: 581
  start-page: 465
  issue: 7809
  year: 2020
  ident: 86027_CR31
  publication-title: Nature
  doi: 10.1038/s41586-020-2196-x
– volume: 27
  start-page: 6383
  issue: 45
  year: 2009
  ident: 86027_CR20
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.08.010
– volume: 17
  start-page: 065007
  year: 2020
  ident: 86027_CR29
  publication-title: Phys. Biol.
  doi: 10.1088/1478-3975/aba6d0
– volume: 2
  start-page: 2
  year: 2020
  ident: 86027_CR5
  publication-title: J. Infect. Dis.
– volume: 117
  start-page: 9122
  issue: 16
  year: 2020
  ident: 86027_CR27
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.2004064117
– volume: 382
  start-page: 727
  issue: 8
  year: 2020
  ident: 86027_CR2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 12
  start-page: 81
  issue: 1
  year: 2006
  ident: 86027_CR19
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1201.051370
– volume: 26
  start-page: 672
  issue: 5
  year: 2020
  ident: 86027_CR30
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0869-5
– volume: 81
  start-page: 107
  issue: 1
  year: 2020
  ident: 86027_CR24
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.04.024
– ident: 86027_CR28
– volume: 12
  start-page: 1671
  issue: 11
  year: 2006
  ident: 86027_CR22
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1211.060255
– ident: 86027_CR26
– ident: 86027_CR3
– volume: 81
  start-page: 816
  issue: 5
  year: 2020
  ident: 86027_CR15
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.06.073
– volume: 5
  start-page: 631
  issue: 23
  year: 2008
  ident: 86027_CR21
  publication-title: J. R. Soc. Interface
  doi: 10.1098/rsif.2007.1197
– volume: 34
  start-page: 13877
  issue: 10
  year: 2020
  ident: 86027_CR16
  publication-title: FASEB J.
  doi: 10.1096/fj.202001700RR
– volume: 2
  start-page: 2
  year: 2020
  ident: 86027_CR9
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 2
  start-page: 2
  year: 2020
  ident: 86027_CR10
  publication-title: Nature
– volume: 12
  start-page: 88
  issue: 1
  year: 2006
  ident: 86027_CR18
  publication-title: Emerg. Infect. Dis.
– volume: 351
  start-page: 368
  issue: 2
  year: 2006
  ident: 86027_CR7
  publication-title: Virology
  doi: 10.1016/j.virol.2006.03.020
– volume: 26
  start-page: 264
  issue: 3
  year: 2020
  ident: 86027_CR13
  publication-title: Hong Kong Med. J.
– volume: 442
  start-page: 448
  issue: 7101
  year: 2006
  ident: 86027_CR11
  publication-title: Nature
  doi: 10.1038/nature04795
– volume: 9
  start-page: e57149
  year: 2020
  ident: 86027_CR32
  publication-title: Elife
  doi: 10.7554/eLife.57149
– ident: 86027_CR8
– volume: 92
  start-page: 645
  issue: 6
  year: 2020
  ident: 86027_CR25
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25750
– volume: 5
  start-page: 59
  year: 2020
  ident: 86027_CR4
  publication-title: Wellcome Open Res.
  doi: 10.12688/wellcomeopenres.15808.1
– volume: 15
  start-page: 265
  issue: 2
  year: 1993
  ident: 86027_CR17
  publication-title: Epidemiol. Rev.
  doi: 10.1093/oxfordjournals.epirev.a036121
– volume: 581
  start-page: 323
  year: 2006
  ident: 86027_CR6
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-0-387-33012-9_57
– volume: 580
  start-page: 316
  issue: 7803
  year: 2020
  ident: 86027_CR12
  publication-title: Nature
  doi: 10.1038/d41586-020-01003-6
SSID ssj0000529419
Score 2.3974059
Snippet After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of...
Abstract After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6856
SubjectTerms 631/114
631/114/2397
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 - transmission
COVID-19 - virology
Disease Outbreaks - prevention & control
Disease transmission
Humanities and Social Sciences
Humans
Infections
Mobility
Models, Statistical
Movement
multidisciplinary
Pandemics
Population density
Quarantine
SARS-CoV-2 - isolation & purification
Science
Science (multidisciplinary)
Stochastic models
Stochastic Processes
Viral infections
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQpUpcEDuBUhmJG1j1Fsc-QhcVJOAARb1Zjh2rldoEta-HnvrXO-PkPRoocOEWx7HlZcYzjsffR8hrsBnWRhmZAGee6WANsyoH_JEfQLfQ6uKJ7qfPZv9AfzysD29QfWFM2AgPPA7cFu9yNp3m2XGrs-EhNjzDyo5bBStiwtUXbN6NzdSI6i2dFm66JcOV3ToHS4W3yaRgSLvUMDmzRAWw_zYv8_dgyV9OTIsh2rtP7k0eJH03tvwBudP1D8n6yCl5-YhcfV0M8Sgg_DItNDd435wOmYKnR6foDUwWcj52OpTg2EuKFB1nx-WSAw19ohj7e0KXoVo9jXNgZwqvsEJoJAgJ1rf95fuHHSbcY3Kwt_tte59NLAssGmEWLMIuzJpkE--UDNK1DaTakLkJCdy3lMBgxdbAs0ptrtsQuQht7WLMKdSZqydkrR_67hmBTohkecxdrmFh6LRtYzbJOdlqBUVkRcRyxH2cIMiRCePEl6NwZf04Sx5myZdZ8lDmzarMjxGA469fv8eJXH2J4NnlBYiUn0TK_0ukKrKxFAM_afS5l4XxT0lub88Gz7DRsPdyFXm1ygZVxfOX0HfDRanCgDfA67oiT0ehWjVUIaqOVKoizUzcZj2Z5_THRwUOvHFOGyUq8nYpmD-b9eeRev4_RuoFuStRo7hist4ga4uzi-4lOGmLdrPo4zVFMDly
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9UwDI9gCIkL4pvCQEHiBtHSpE2TE4LBNJCAAwy9W5QmzTZptOO9t8NO_OvYaV6nwtitbZooie3YiR3_CHkJOkNrLzwrwZhnldOKaRkdHuQ7kC3UuujR_fxF7R9Unxb1Ih-4rXJY5WZNTAt1GDyeke-IhLgmBddvTn8xRI1C72qG0LhObmDqMuTqZtFMZyzoxapKk-_KcKl3VqCv8E6ZKBmCLzVMzPRRStt_ma35b8jkX37TpI727pDb2Y6kb0fC3yXXuv4euTkiS57fJ7-_rQd_5DAJM01gN3jrnA6Rgr1HcwwHviaIPvZzSCGy5xSBOpbH6aoDdX2gGAF8QjcBWz318_TOFD5hg9BJYBVsb_frj4_vWWkekIO9D99391nGWmBelWrNPOzFtAo68E4KJ0zbwFvrIlcugBEXAqgt3yp4lqGNdes8L11bG-9jcHXk8iHZ6oe-e0xgEGXQ3Mcu1rA8dJVufVTBGNFWEqqIgpSbGbc-JyJHPIwTmxziUtuRShaoZBOVLNR5NdU5HdNwXPn3OyTk9Cem0E4fhuWhzRJpOUy26ioeDddVVNz5hkcwGXAPqksfCrK9YQOb5XplL7jw8mKwD5sKdmCmIC-mYhBY9MK4vhvOUhMKbAJe1wV5NDLV1FGJuXWElAVpZuw2G8m8pD8-SknBG2MqJcuCvN4w5kW3_j9TT64e5FNyS6CscMlEvU221suz7hkYYev2eZK0P9L4L_w
  priority: 102
  providerName: ProQuest
– databaseName: HAS SpringerNature Open Access 2022
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqVkhcEG8CBRmJG1j4kTj2cSlUZSXgUIp6sxw7ppVKgrbbQ0_8dWacZFFgQeIWxw_5MeOZZGa-IeQFyAxjggxMgDLPSm80Myp5_JHvgbdQ6qJF98NHfXRSLk-r0x0ip1iY7LSfIS3zNT15h72-BEGDwWBSMMyaVDO4dvcQqh1oe2-xWB4vN39W0HZVCjtGyHBltnSeSaEM1r9Nw_zTUfI3a2kWQoe3ya1Re6SLYb53yE7b3SU3hnyS1_fIj-N1H848Qi_TnOIGY81pnyhoeXT03MBiTszHvvXZMfaaYnqO1XkOcKC-ixT9fi_o5KbV0TAHdabwCgeESQKB4HgHn768f8uEvU9ODt99PjhiY4YFFrTQaxbgC8zoaCJvlfTSNjWUGp-49hFUtxhBWIVGw7OKTaoaH7jwTWVDSNFXiasHZLfru_YRgUWIaHhIbargUmhL04Sko7WyKRV0kQUR0467MMKPYxaMC5fN4Mq44ZQcnJLLp-Sgz8tNn-8D-MY_W7_Bg9y0RODs_KJffXUjITkOm63bkifLTZk096HmCRQF_PI0IsSC7E9k4EZuvnQyZ_tTkpvt1aAVAiWayhbk-aYa2BRtL75r-6s8hAZNgFdVQR4ORLWZqEJEHalUQeoZuc1WMq_pzs8yFHhtbamVKMiriTB_TevvO_X4_5o_ITcl8g5XTFb7ZHe9umqfgiq2bp6NvPcTEzQvOQ
  priority: 102
  providerName: Springer Nature
Title Stochastic modelling of the effects of human-mobility restriction and viral infection characteristics on the spread of COVID-19
URI https://link.springer.com/article/10.1038/s41598-021-86027-2
https://www.ncbi.nlm.nih.gov/pubmed/33767233
https://www.proquest.com/docview/2505253208
https://www.proquest.com/docview/2615745859
https://www.proquest.com/docview/2506284055
https://pubmed.ncbi.nlm.nih.gov/PMC7994631
https://doaj.org/article/0eff6e40f9084f60ac70fcee282881cd
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELbGJiReEL8XGJWReAODYyeO84BQVzaNShuIUdS3yLFjNqkkW9dJ9Il_nTsnKSoUxFMbO7Yc-y73Ob67j5DnYDO0tsKyGMA8S4xWTEtv8EO-Ad1Cq4snuscn6miSjKfpdIv0dEfdBF5t3Nohn9RkPnv1_XL5FhT-TRsyrl9fgRHCQDERM2RUyhi8knfAMmXIaHDcwf0217fIk8D1gUnYGYAJ0cXRbO5mzVaFlP6bcOif7pS_nakGU3V4h9zuMCYdtkJxl2xV9T1ys2WdXN4nP04XjT0zmKCZBiIcjEinjaeABWnn34GXgb6PfWuC--ySIonH_DyEQVBTO4rewTPaO3PV1K6nfqZQhB3CIEGMsL_Rhy_v37E4f0AmhwefR0es42FgVsVqwSzs07Ry2vFKCiPyMoOr0niujAOA5xyYNFsq-C9d6dPSWB6bMs2t9c6knsuHZLtu6mqXwEPETnPrK5_Cq6NKdGm9cnkuykRCExGRuJ_xwnZJypErY1aEw3Kpi3aVClilIqxSAW1erNpctCk6_nn3Pi7k6k5Mrx0KmvnXotPWgsNkqyrhPuc68Yobm3EPcAL3pzq2LiJ7vRgUvcgWInACSsH15mrAjlkCu7M8Is9W1aDMeEJj6qq5Dl0owAs8TSPyqBWq1UAl5t0RUkYkWxO3tSdZr6nPz0LC8CzPEyXjiLzsBfPXsP4-U4__Y5hPyC2BCsMlE-ke2V7Mr6ungNIW5YDcyKbZgOwMh-PTMfzuH5x8_ASlIzUahC8fg6CcPwGgIjzy
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2ggJHgBFYdO3GcA0LQUu3SBwdatLfg2DGtVJKyuxXaE_-I38iM86gWSm-9JXFs2Z7xzNgzno-QF6AztLbCshiMeZYYrZiW3uBBvoG1hVoXPbq7e2p0kHycpJMV8ru_C4Nhlb1MDILaNRbPyNdFQFyTguu3Jz8Yokahd7WH0GjZYrta_IQt2-zNeBPo-1KIrQ_7GyPWoQowq2I1ZxZ2HVo57XglhRF5mcFbaTxXxoG54hwIaFsqeJau9GlpLI9NmebWemdSzyW0e4VcBcXLcbOXTbLhTAe9Zkmcd3dzuNTrM9CPeIdNxAzBnjImlvRfgAk4z7b9N0TzLz9tUH9bt8jNzm6l71pGu01WqvoOudYiWS7ukl-f5409NJj0mQZwHbzlThtPwb6kXcwIvgZIQPa9CSG5C4rAINOjcLWCmtpRjDg-pn2AWE3tcjppCp-wQegksCa2t_Hpy3iTxfk9cnApVLhPVuumrh4SGETsNLe-8imIoyrRpfXK5bkoEwlVRETifsYL2yU-R_yN4yI44KUuWioVQKUiUKmAOq-GOidt2o8L_36PhBz-xJTd4UMz_VZ0EqDgMNmqSrjPuU684sZm3IOJgnteHVsXkbWeDYpOjsyKM64_vxjs0SyBHV8ekedDMQgI9PqYumpOQxMKbBCephF50DLV0FGJuXyElBHJlthtaSTLJfXRYUhCnuV5omQckdc9Y5516_8z9ejiQT4j10f7uzvFznhv-zG5IXDdcMlEukZW59PT6gkYgPPyaVh1lHy97GX-B9Y4byE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKViAuiDeBAkaCE1jr2InjHBCi3a5aCksFtOotOHZMK5Wk7G6F9sT_4tcx4022Wii99ZbEsWV7Hh57xvMR8hzWDK2tsCwGY54lRiumpTd4kG9AtnDVRY_uh5Ha2kveHaQHK-R3dxcGwyo7nRgUtWssnpH3RUBck4Lrvm_DInYHwzcnPxgiSKGntYPTmLPITjX7Cdu3yevtAdD6hRDDzS8bW6xFGGBWxWrKLOxAtHLa8UoKI_Iyg7fSeK6MA9PFOVDWtlTwLF3p09JYHpsyza31zqSeS2j3ClnNcFfUI6vrm6PdT4sTHvShJXHe3tThUvcnsFrijTYRM4R-yphYWg0DaMB5lu6_AZt_eW3DYji8SW60Vix9O2e7W2Slqm-Tq3Ncy9kd8uvztLGHBlNA0wC1g3feaeMpWJu0jSDB1wAQyL43IUB3RhEmZHwULlpQUzuK8cfHtAsXq6ldTi5N4RM2CJ0ERsX2Nj7ubw9YnN8le5dCh3ukVzd19YDAIGKnufWVT0E5VYkurVcuz0WZSKgiIhJ3M17YNg06onEcF8EdL3Uxp1IBVCoClQqo83JR52SeBOTCv9eRkIs_MYF3-NCMvxWtPig4TLaqEu5zrhOvuLEZ92Cw4A5Yx9ZFZK1jg6LVKpPiTAbOLwbrNEtg_5dH5NmiGNQF-oBMXTWnoQkFFglP04jcnzPVoqMSM_sIKSOSLbHb0kiWS-qjw5CSPMvzRMk4Iq86xjzr1v9n6uHFg3xKroGIF--3RzuPyHWBYsMlE-ka6U3Hp9VjsAan5ZNW7Cj5etmS_gcYX3S8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stochastic+modelling+of+the+effects+of+human-mobility+restriction+and+viral+infection+characteristics+on+the+spread+of+COVID-19&rft.jtitle=Scientific+reports&rft.au=Ando%2C+Shiho&rft.au=Matsuzawa%2C+Yuki&rft.au=Tsurui%2C+Hiromichi&rft.au=Mizutani%2C+Tetsuya&rft.date=2021-03-25&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft.spage=6856&rft_id=info:doi/10.1038%2Fs41598-021-86027-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon